Benuvia

At Benuvia, we help clients navigate the complexities of the development and manufacture of controlled substances for novel therapies, offering complete control over the drug development process. As a specialized CDMO offering small molecule API and finished dose development and cGMP manufacturing services, we specialize in the formulation, synthesis, and production of highly regulated and complex compounds, delivering end-to-end solutions tailored to our clients’ needs. We provide the expertise, process optimization, scale-up capabilities, and infrastructure to accelerate time-to-market while also reducing costs. Benuvia is a pioneer in the development and manufacturing of controlled substances with over 15 years of experience in cannabinoids, psychedelics, and other highly regulated compounds. We are the go-to partner for companies seeking high-quality products, robust regulatory compliance, and a first-class customer experience. Benuvia has been at the forefront of cannabinoid innovation since 2009, manufacturing pharmaceutical-grade, cGMP pure cannabidiol (CBD). Our expertise extends to other highly controlled substances, allowing us to support therapies in emerging fields like psychedelics. From formulation to API synthesis and robust analytical development to manufacturing, packaging, serialized labeling, warehousing, import and export capabilities, and regulatory affairs, Benuvia offers a comprehensive suite of solutions to meet your clinical and commercial goals. Located near Austin, TX, in Round Rock, our 83,000-square-foot, purpose built, state-of-the-art facility is DEA and FDA registered and fully compliant with cGMP standards, as well as the DEA, EPA, and OSHA. These certifications, along with our proven track record in controlled substances, ensure the highest levels of quality, safety, and compliance for your products. Benuvia helps you navigate the unique challenges of controlled substances with tailored global solutions. Reach out today.